Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Avidity Biosciences

Tracked across 3 events · 35 articles · First seen Sep 01, 2026 · Last active Sep 11, 2026

Sentiment
-20
Attention
6
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 -30
Business
Novartis announced on September 8, 2026 that its Phase III HARBOR study of del-desiran, an antibody oligonucleotide conjugate for myotonic dystrophy type 1 (DM1), failed to show statistically significant improvement versus placebo on the primary…
Impact: Avidity was acquired by Novartis for about $12 billion, and the failure of del-desiran, one of its lead AOC assets, has dented confidence in the value and rationale of that acquisition.
Sep 08, 2026 · 21 articles
4 -30
Business
Artisan Partners Asset Management, a top-20 shareholder in Swiss drugmaker Novartis, publicly called for a shake-up of the company's board to improve corporate governance and oversight of acquisitions. David Samra, managing director at Artisan Partners…
Impact: U.S. firm acquired by Novartis for $12 billion whose muscle-wasting disorder drug failed a late-stage study, triggering the share slump.
Sep 10, 2026 · 6 articles
1 0
Business
Impact: Avidity Biosciences is mentioned as Davé's previous employer, providing context for his experience. No direct impact on Avidity from this event.
Sep 01, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Avidity Biosciences live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.